This monograph explains the considerable impact that monoclonal
antibodies and molecular probes have had on the diagnosis of tumor
types and sub-types. It explains how radiolabelled monoclonal
antibodies have also been used as imaging agents to try to improve
the oncologist's ability to define residual tumor deposits after
combination chemo/radiotherapy. Finally, the childhood malignancies
that still have a poor prognosis are presented, and new novel ways
of therapy are explained.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!